MEI Pharma, Inc. (Nasdaq:MEIP)
Health Care/Life Sciences • Pharmaceuticals
CIK 1262104
Company
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
Address
11455 El Camino Real
Suite 250
San Diego, California 92130
11455 El Camino Real
Suite 250
San Diego, California 92130
Employees
46
46
Stock Info
Close
$3.9800
$3.9800
Day Range
3.9800 - 4.2493
3.9800 - 4.2493
52 Week Range
3.9800 - 7.9700
3.9800 - 7.9700
Average volume
29.34K
29.34K
Short Interest
10.12K (02/15/24)
10.12K (02/15/24)
% of Float Shorted
0.16%
0.16%
Market Cap
$28.25M
$28.25M
Revenue
$48.82M
$48.82M
Net Income
-$31.84M
-$31.84M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director David M Urso |
Director James Flynn CFA |
Director Taheer Mehboob Datoo |
Director Steven Duncan Wood CFA |
Chairman Charles V Baltic III, MBA |
Independent Non-Executive Director Nicholas R Glover PhD |
Independent Non-Executive Director Frederick W Driscoll |
Independent Non-Executive Director Thomas C Reynolds MD, PhD |
SEC filings
Date | Form | Event |
---|---|---|
20 Dec, 2024 | DEF 14A | |
20 Dec, 2024 | DEFA14A | |
20 Dec, 2024 | ARS | |
25 Nov, 2024 | 8-K | |
14 Nov, 2024 | 8-K | |
12 Nov, 2024 | 10-Q | |
25 Oct, 2024 | 8-K | |
19 Sep, 2024 | 8-K | |
19 Sep, 2024 | 10-K | |
2 Aug, 2024 | 8-K | |
30 Jul, 2024 | 8-K | |
22 Jul, 2024 | 144 | |
22 Jul, 2024 | 8-K | |
25 Jun, 2024 | 8-K | |
21 May, 2024 | 8-K | |
21 May, 2024 | 4 | |
20 May, 2024 | 4 | |
9 May, 2024 | 8-K | |
9 May, 2024 | 10-Q | |
28 Feb, 2024 | EFFECT | |
28 Feb, 2024 | 424B5 | |
26 Feb, 2024 | CORRESP | |
23 Feb, 2024 | UPLOAD | |
21 Feb, 2024 | 8-K | |
20 Feb, 2024 | S-3 | |
14 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | 8-K | |
13 Feb, 2024 | 10-Q | |
17 Jan, 2024 | 8-K | |
12 Jan, 2024 | 4/A | |
12 Jan, 2024 | 4/A | |
26 Dec, 2023 | 8-K | |
22 Dec, 2023 | 8-K | |
20 Dec, 2023 | 4 | |
20 Dec, 2023 | 4 | |
18 Dec, 2023 | 8-K | |
11 Dec, 2023 | 8-K | |
14 Nov, 2023 | 3 | |
9 Nov, 2023 | 10-Q | |
9 Nov, 2023 | 8-K | |
8 Nov, 2023 | DEFA14A | |
8 Nov, 2023 | DEF 14A | |
8 Nov, 2023 | ARS | |
6 Nov, 2023 | 3 | |
3 Nov, 2023 | 3 | |
1 Nov, 2023 | 8-K | |
1 Nov, 2023 | SC 13D/A | |
1 Nov, 2023 | DFAN14A | |
1 Nov, 2023 | DEFA14A | |
27 Oct, 2023 | 10-K/A | |
24 Oct, 2023 | SC 13D/A | |
24 Oct, 2023 | 4 | |
24 Oct, 2023 | 4 | |
18 Oct, 2023 | DEFA14A | |
17 Oct, 2023 | DEFC14A | |
13 Oct, 2023 | SC 13D/A | |
13 Oct, 2023 | 4 | |
13 Oct, 2023 | 4 | |
12 Oct, 2023 | 4 | |
12 Oct, 2023 | CORRESP | |
12 Oct, 2023 | 4 | |
12 Oct, 2023 | PRER14A | |
12 Oct, 2023 | 4 | |
12 Oct, 2023 | 4 | |
12 Oct, 2023 | 4 | |
12 Oct, 2023 | 4 | |
12 Oct, 2023 | 4 | |
12 Oct, 2023 | 4 | |
10 Oct, 2023 | DEFC14A | |
10 Oct, 2023 | DFAN14A | |
3 Oct, 2023 | 8-K | |
3 Oct, 2023 | 8-A12B | |
2 Oct, 2023 | DEFA14A | |
29 Sep, 2023 | PREC14A | |
29 Sep, 2023 | DFAN14A | |
28 Sep, 2023 | CORRESP | |
28 Sep, 2023 | PRER14A | |
28 Sep, 2023 | DEFA14A | |
26 Sep, 2023 | 10-K | |
26 Sep, 2023 | SC 13D/A | |
26 Sep, 2023 | 8-K | |
26 Sep, 2023 | DEFC14A | |
26 Sep, 2023 | DFAN14A | |
25 Sep, 2023 | UPLOAD | |
25 Sep, 2023 | 4 | |
25 Sep, 2023 | 4 | |
22 Sep, 2023 | 4 | |
22 Sep, 2023 | SC 13D/A | |
22 Sep, 2023 | 4 | |
22 Sep, 2023 | PX14A6G | |
22 Sep, 2023 | DFAN14A | |
18 Sep, 2023 | CORRESP | |
18 Sep, 2023 | DEFA14A | |
15 Sep, 2023 | PREC14A | |
15 Sep, 2023 | SC 13D/A | |
8 Aug, 2023 | SC 13D/A | |
4 Aug, 2023 | PRRN14A | |
1 Aug, 2023 | 3 | |
27 Jul, 2023 | 8-K | |
24 Jul, 2023 | 8-K | |
19 Jul, 2023 | 425 | |
19 Jul, 2023 | DFAN14A | |
19 Jul, 2023 | 8-K | |
18 Jul, 2023 | 8-K | |
18 Jul, 2023 | 425 | |
17 Jul, 2023 | DFAN14A | |
17 Jul, 2023 | 8-K | |
17 Jul, 2023 | SC 13D/A | |
17 Jul, 2023 | 425 | |
17 Jul, 2023 | PREC14A | |
13 Jul, 2023 | 424B3 | |
13 Jul, 2023 | 8-K | |
13 Jul, 2023 | 425 | |
10 Jul, 2023 | PX14A6G | |
7 Jul, 2023 | 8-K | |
7 Jul, 2023 | 425 | |
5 Jul, 2023 | 8-K | |
5 Jul, 2023 | 425 | |
3 Jul, 2023 | 424B3 | |
29 Jun, 2023 | 8-K | |
29 Jun, 2023 | 425 | |
28 Jun, 2023 | 8-K | |
28 Jun, 2023 | 425 | |
14 Jun, 2023 | S-8 | |
13 Jun, 2023 | 425 | |
13 Jun, 2023 | 8-K | |
6 Jun, 2023 | 424B3 | |
6 Jun, 2023 | EFFECT | |
6 Jun, 2023 | 4 | |
5 Jun, 2023 | S-4/A | |
5 Jun, 2023 | CORRESP | |
2 Jun, 2023 | 425 | |
2 Jun, 2023 | 8-K | CEO Change |
1 Jun, 2023 | DEFA14A | |
1 Jun, 2023 | 8-K | |
31 May, 2023 | 8-K | |
31 May, 2023 | DEFA14A | |
30 May, 2023 | SC 13D | |
30 May, 2023 | 3 | |
30 May, 2023 | 3 | |
11 May, 2023 | 10-Q | |
11 May, 2023 | 8-K | |
1 May, 2023 | SC 13G | |
1 May, 2023 | UPLOAD | |
28 Apr, 2023 | S-4 | |
14 Apr, 2023 | 8-K | |
13 Mar, 2023 | 8-K | |
9 Mar, 2023 | SC 13D/A | |
1 Mar, 2023 | 4 | |
24 Feb, 2023 | 425 | |
23 Feb, 2023 | 8-K | CEO Change |
23 Feb, 2023 | 425 | |
14 Feb, 2023 | SC 13G | |
9 Feb, 2023 | 8-K | |
9 Feb, 2023 | SC 13G | |
9 Feb, 2023 | S-8 | |
9 Feb, 2023 | 10-Q | |
9 Feb, 2023 | SC 13G/A | |
6 Jan, 2023 | 8-K | |
8 Dec, 2022 | 8-K | |
14 Nov, 2022 | 10-Q | |
14 Nov, 2022 | 8-K | |
27 Oct, 2022 | DEF 14A | |
14 Oct, 2022 | PRE 14A | |
7 Oct, 2022 | 8-K | |
15 Sep, 2022 | 8-K | |
8 Sep, 2022 | 10-K | |
7 Jul, 2022 | 8-K | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
7 Jul, 2022 | 4 | |
31 May, 2022 | SC 13G/A | |
23 May, 2022 | 10-Q/A | |
23 May, 2022 | 10-Q/A | |
23 May, 2022 | 10-Q | |
23 May, 2022 | 8-K | |
23 May, 2022 | 10-K/A | |
17 May, 2022 | NT 10-Q | |
13 May, 2022 | 8-K | |
7 Apr, 2022 | SC 13G/A | |
25 Mar, 2022 | 8-K | |
14 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13G | |
10 Feb, 2022 | 10-Q | |
9 Feb, 2022 | SC 13G/A | |
1 Feb, 2022 | SC 13G/A | |
23 Dec, 2021 | 8-K | |
17 Dec, 2021 | 8-K | |
6 Dec, 2021 | 8-K | |
2 Dec, 2021 | 424B5 | |
30 Nov, 2021 | 424B5 | |
30 Nov, 2021 | 8-K | |
23 Nov, 2021 | DEFA14A | |
23 Nov, 2021 | 4 | |
23 Nov, 2021 | 8-K | |
23 Nov, 2021 | 3 | |
10 Nov, 2021 | 10-Q | |
28 Oct, 2021 | DEF 14A | |
28 Oct, 2021 | DEFA14A | |
6 Oct, 2021 | PRE 14A | |
2 Sep, 2021 | 10-K | |
5 Aug, 2021 | 8-K | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
6 Jul, 2021 | 4 | |
14 Jun, 2021 | 8-K | |
27 May, 2021 | 4 | |
6 May, 2021 | 10-Q | |
6 May, 2021 | S-8 | |
5 May, 2021 | 3 | |
5 May, 2021 | 4 | |
30 Apr, 2021 | 8-K | |
13 Apr, 2021 | 8-K | |
24 Feb, 2021 | 4 | |
16 Feb, 2021 | SC 13G/A | |
16 Feb, 2021 | SC 13G/A | |
12 Feb, 2021 | SC 13G/A | |
11 Feb, 2021 | SC 13G/A | |
4 Feb, 2021 | 10-Q | |
2 Feb, 2021 | SC 13G | |
8 Jan, 2021 | S-8 |
Last update:2024-03-06 12:36:27.082765
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.